Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.10%126.45M | 2.50%126.11M | -3.63%116.21M | -8.43%490.18M | -3.60%121.48M | -6.89%125.08M | -14.45%123.04M | -8.05%120.59M | 5.50%535.32M | -2.18%126.02M |
Operating revenue | 1.10%126.45M | 2.50%126.11M | -3.63%116.21M | -8.43%490.18M | -3.60%121.48M | -6.89%125.08M | -14.45%123.04M | -8.05%120.59M | 5.50%535.32M | -2.18%126.02M |
Cost of revenue | -1.34%47.19M | 5.50%50M | -9.69%42.95M | -17.24%188.03M | -16.58%45.25M | -11.66%47.83M | -25.33%47.39M | -14.06%47.56M | 0.84%227.2M | -16.29%54.25M |
Gross profit | 2.61%79.26M | 0.62%76.11M | 0.31%73.27M | -1.94%302.15M | 6.22%76.23M | -3.67%77.24M | -5.85%75.64M | -3.66%73.04M | 9.22%308.12M | 12.11%71.77M |
Operating expense | 0.32%91.51M | -5.69%81.81M | -3.66%83.86M | -6.53%347.67M | -2.23%82.68M | -10.52%91.21M | -3.07%86.74M | -9.29%87.04M | -1.15%371.95M | -14.46%84.57M |
Selling and administrative expenses | 0.32%91.51M | -5.69%81.81M | -3.66%83.86M | -6.53%347.67M | -2.23%82.68M | -10.52%91.21M | -3.07%86.74M | -9.29%87.04M | -1.15%371.95M | -14.46%84.57M |
-Selling and marketing expense | 5.74%64.06M | 0.93%52.75M | 1.80%54.83M | 15.22%79.28M | -668.98%-87.43M | 178.57%60.58M | 240.93%52.27M | 229.17%53.86M | -7.54%68.81M | 14.98%15.37M |
-General and administrative expense | -10.39%27.45M | -15.72%29.06M | -12.51%29.03M | -11.46%268.39M | 145.82%170.11M | -61.80%30.63M | -53.51%34.47M | -58.31%33.18M | 0.42%303.14M | -19.06%69.2M |
Operating profit | 12.34%-12.25M | 48.68%-5.7M | 24.36%-10.59M | 28.69%-45.52M | 49.60%-6.45M | 35.77%-13.97M | -21.35%-11.1M | 30.46%-14M | 32.23%-63.83M | 63.27%-12.8M |
Net non-operating interest income expense | -38.48%502K | 5.71%666K | 1.32%768K | 172.78%3.18M | 359.68%979K | 164.45%816K | 147.01%630K | 154.57%758K | 19.99%-4.37M | 71.50%-377K |
Non-operating interest income | -31.37%1.18M | -32.21%1.35M | -30.79%1.48M | 613.35%7.53M | 71.98%1.68M | 2,102.56%1.72M | --2M | --2.14M | --1.06M | --978K |
Non-operating interest expense | -24.94%677K | -49.71%687K | -48.44%711K | -19.84%4.35M | -48.12%703K | -32.89%902K | 1.94%1.37M | --1.38M | -0.66%5.43M | --1.36M |
Other net income (expense) | -92.32%234K | -276.52%-233K | -113.58%-215K | -20.29%5.33M | 155.56%570K | 74.50%3.05M | 186.27%132K | -74.13%1.58M | -78.68%6.68M | -89.65%-1.03M |
Gain on sale of security | -66.62%261K | -500.77%-521K | -129.98%-391K | -48.82%2.74M | 144.50%522K | -50.00%782K | 112.52%130K | -78.25%1.3M | -83.83%5.35M | -102.24%-1.17M |
Special income (charges) | --0 | ---- | ---- | --1.83M | --0 | --1.83M | ---- | ---- | --0 | --0 |
-Less:Other special charges | ---- | ---- | ---- | ---1.83M | --0 | ---1.83M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -106.21%-27K | 14,300.00%288K | -36.92%176K | -42.88%762K | -67.35%48K | 140.33%435K | -99.77%2K | 126.83%279K | 385.09%1.33M | 276.92%147K |
Income before tax | -13.86%-11.51M | 49.09%-5.26M | 13.92%-10.04M | 39.84%-37.01M | 65.48%-4.9M | 52.48%-10.11M | 2.84%-10.34M | 24.31%-11.66M | 9.93%-61.52M | 61.31%-14.2M |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | -13.86%-11.51M | 49.09%-5.26M | 13.92%-10.04M | 39.84%-37.01M | 65.48%-4.9M | 52.48%-10.11M | 2.84%-10.34M | 24.31%-11.66M | 9.93%-61.52M | 61.31%-14.2M |
Net income continuous Operations | -13.86%-11.51M | 49.09%-5.26M | 13.92%-10.04M | 39.84%-37.01M | 65.48%-4.9M | 52.48%-10.11M | 2.84%-10.34M | 24.31%-11.66M | 9.93%-61.52M | 61.31%-14.2M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -13.86%-11.51M | 49.09%-5.26M | 13.92%-10.04M | 39.84%-37.01M | 65.48%-4.9M | 52.48%-10.11M | 2.84%-10.34M | 24.31%-11.66M | 9.93%-61.52M | 61.31%-14.2M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -13.86%-11.51M | 49.09%-5.26M | 13.92%-10.04M | 39.84%-37.01M | 65.48%-4.9M | 52.48%-10.11M | 2.84%-10.34M | 24.31%-11.66M | 9.93%-61.52M | 61.31%-14.2M |
Basic earnings per share | -16.67%-0.07 | 50.00%-0.03 | 14.29%-0.06 | 40.00%-0.21 | 62.50%-0.03 | 50.00%-0.06 | 0.00%-0.06 | 22.22%-0.07 | 20.45%-0.35 | 62.04%-0.08 |
Diluted earnings per share | -16.67%-0.07 | 50.00%-0.03 | 14.29%-0.06 | 40.00%-0.21 | 62.50%-0.03 | 50.00%-0.06 | 0.00%-0.06 | 22.22%-0.07 | 20.45%-0.35 | 62.04%-0.08 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |